The June issue of Ultrasound in Obstetrics & Gynecology includes an article on the available evidence regarding intrauterine vertical transmission of SARS-CoV-2, studies on the cost-effectiveness of prenatal screening strategies for congenital heart defects and reasons for a missed diagnosis, with an accompanying Editorial, a study on the role of Doppler ultrasound at the time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome, a study presenting diagnostic criteria for T-shaped uterus, and updated ISUOG Interim Guidance on COVID-19 during pregnancy and puerperium.
We have reimagined the ISUOG World Congress to make it more accessible for our international community and to respond to the current global crisis.
Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study
ISUOG is participating in the World Pre-eclampsia Day to bring greater awareness to prevention, diagnosis and management of pre-eclampsia.
Effects of coronavirus disease 2019 on maternal, perinatal and neonatal outcomes: a systematic review
Read the latest article from Ultrasound in Obstetrics & Gynecology on Effects of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcomes: a systematic review.
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.21991
The Trustees and the President are pleased to announce that Johan Vos has been offered a permanent position as Chief Executive Officer of ISUOG.
Prof. David Williams (United Kingdom)
Deberia de usarse la prueba de ADN celular libre en embarazos con translucencia nucal fetal aumentada?
Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
The May issue of Ultrasound in Obstetrics & Gynecology includes an Opinion presenting ultrasound images of fetal abnormalities before 11 weeks, a ‘How to’ article on performing lung ultrasound in pregnant women with suspected COVID-19, a study assessing the impact of the Growth Assessment Protocol program on stillbirth rate in over 11 million births, and a study on whether cell-free DNA testing should be used in pregnancy with increased fetal nuchal translucency. Also online this month are new ISUOG Practice Guidelines on the role of ultrasound in the diagnosis and management of congenital infection, and updated Interim Guidance on COVID-19 during pregnancy and puerperium.
Diagnostico de defectos fetales en embarazos gemelares al examen ultrasonográfico de rutina a las 11–13 semanas
The novel coronavirus disease (COVID‐19) is a global public health emergency. There are concerns relating to the impact of SARS-CoV-2 infection on pregnant women and their fetuses, and patient management in the context of COVID-19 poses a challenge. This Virtual Issue compiles the latest research, guidance and opinions published in Ultrasound in Obstetrics and Gynecology on COVID-19 in the obstetric and gynecological settings, including management of infected pregnant women, rationalization of ultrasound services and risk mitigation for both patients and practitioners during the current pandemic.
Read the latest opinion summarizing the current data on the risk of vertical transmission of SARS-CoV-2 during pregnancy.
UK stillbirth trends in over 11 million births provide no evidence to support effectiveness of Growth Assessment Protocol program
A new study questions the impact of the Growth Assessment Protocol program on stillbirth rates.